Literature DB >> 3894235

Kinetics of assembly and decay of complement components on Escherichia coli O111:B4 preparation of stable intermediates.

G Rottini, F Tedesco, M Basaglia, L Roncelli, P Patriarca.   

Abstract

The preparation of bacterial intermediates bearing complement components at various steps of the complement sequence was investigated by suspending immunoglobulin M-opsonized Escherichia coli O111:B4 cells in complement-deficient sera at different temperatures and ionic strengths. The optimal conditions for the formation of the intermediates at Tmax were found to be an ionic strength of 0.091 mu and a temperature of 37 degrees C, except for BAC142, which could be formed equally well at room temperature. In contrast to all the other intermediates, which, once formed at Tmax, were stable in the presence of the whole serum, BAC142 decayed with a half-life of 10 min due to the lability of bound C2. Washing with a buffer of either 0.091 or 0.046 mu did not affect the bacterial intermediates, with the exception of BAC1-3 formed either in the presence of C5-deficient serum or with purified C3 added to BAC142. All the intermediates were found to be stable after incubation in 0.091-mu buffer for 30 min at 37 degrees C.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3894235      PMCID: PMC262030          DOI: 10.1128/iai.49.2.402-406.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  20 in total

1.  Modulation of the classical pathway C3 convertase by plasma proteins C4 binding protein and C3b inactivator.

Authors:  I Gigli; T Fujita; V Nussenzweig
Journal:  Proc Natl Acad Sci U S A       Date:  1979-12       Impact factor: 11.205

2.  Studies on the reaction of the sixth component of rabbit complement.

Authors:  U Rother; G Till; R Thumb
Journal:  Z Immunitatsforsch Exp Klin Immunol       Date:  1973-12

3.  The ninth component of human complement: purification and physicochemical characterization.

Authors:  G Biesecker; H J Müller-Eberhard
Journal:  J Immunol       Date:  1980-03       Impact factor: 5.422

4.  Moculating effect of the late-acting components of the complement system on the bactericidal activity of human polymorphonuclear leukocytes on E. coli 0111:B4.

Authors:  F Tedesco; G Rottini; P Patriarca
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

5.  A familial dysfunction of the eight component of complement (C8).

Authors:  F Tedesco; M Bardare; A M Giovanetti; G Sirchia
Journal:  Clin Immunol Immunopathol       Date:  1980-06

6.  A lupus-like syndrome in a patient with deficiency of the sixth component of complement.

Authors:  F Tedesco; C M Silvani; M Agelli; A M Giovanetti; S Bombardieri
Journal:  Arthritis Rheum       Date:  1981-11

7.  The reaction mechanism of human C5 in immune hemolysis.

Authors:  N R Cooper; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1970-10-01       Impact factor: 14.307

8.  The eighth component of human complement. Purification and physicochemical characterization of its unusual subunit structure.

Authors:  E W Steckel; R G York; J B Monahan; J M Sodetz
Journal:  J Biol Chem       Date:  1980-12-25       Impact factor: 5.157

9.  Purification from guinea pig erythrocyte stroma of a decay-accelerating factor for the classical c3 convertase, C4b,2a.

Authors:  A Nicholson-Weller; J Burge; K F Austen
Journal:  J Immunol       Date:  1981-11       Impact factor: 5.422

10.  Identification of the membrane glycoprotein that is the C3b receptor of the human erythrocyte, polymorphonuclear leukocyte, B lymphocyte, and monocyte.

Authors:  D T Fearon
Journal:  J Exp Med       Date:  1980-07-01       Impact factor: 14.307

View more
  1 in total

1.  Bactericidal-activities of human polymorphonuclear leukocyte proteins against Escherichia coli O111:B4 coated with C5 or C8.

Authors:  F Tedesco; G Rottini; L Roncelli; M Basaglia; R Menegazzi; P Patriarca
Journal:  Infect Immun       Date:  1986-10       Impact factor: 3.441

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.